1. Home
  2. DNOW vs DNLI Comparison

DNOW vs DNLI Comparison

Compare DNOW & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOW Inc.

DNOW

NOW Inc.

HOLD

Current Price

$15.72

Market Cap

2.8B

Sector

Industrials

ML Signal

HOLD

Logo Denali Therapeutics Inc.

DNLI

Denali Therapeutics Inc.

HOLD

Current Price

$18.50

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNOW
DNLI
Founded
1862
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
3.4B
IPO Year
2014
2017

Fundamental Metrics

Financial Performance
Metric
DNOW
DNLI
Price
$15.72
$18.50
Analyst Decision
Buy
Strong Buy
Analyst Count
4
20
Target Price
$18.75
★ $35.75
AVG Volume (30 Days)
★ 2.1M
1.7M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $2,648,000,000.00
N/A
Revenue This Year
$79.69
N/A
Revenue Next Year
$6.97
$158.26
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 25.68
N/A
52 Week Low
$10.94
$13.75
52 Week High
$17.26
$27.30

Technical Indicators

Market Signals
Indicator
DNOW
DNLI
Relative Strength Index (RSI) 50.71 40.38
Support Level $15.14 $18.07
Resistance Level $16.33 $20.84
Average True Range (ATR) 0.57 0.81
MACD 0.02 0.10
Stochastic Oscillator 57.02 43.07

Price Performance

Historical Comparison
DNOW
DNLI

About DNOW NOW Inc.

Dnow Inc is a provider of energy and industrial solutions and a distributor of pipe, valves, and fittings (PVF) and pumps, as well as fabrication, assembly, and testing of process and production equipment. It provides a broad mix of products required to build and maintain essential infrastructure and operating equipment across upstream, midstream, gas utilities, downstream, energy transition, and industrial markets, along with value-added supply chain solutions and technical product expertise supported by digital offerings through its DigitalNOW and MRCGO e-commerce platforms. The company operates mainly under the DNOW and MRC brands and has three reportable segments: the United States, which generates the majority of revenue, Canada, and International.

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegenerative diseases. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others. The Company has one operating segment with the goal to discover, develop, and commercializing therapeutics.

Share on Social Networks: